Patent Assignment
Reel/Frame 053690/0949
Assignment of Assignor's Interest
Recorded: 2020-09-03
Pages: 8
Assignee
ADAMIS PHARMACEUTICALS CORPORATION
11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CALIFORNIA, 92130
Covered Properties
(4)
Formulation Including a Combination of B-Endorphin and Adrenocorticotropic Hormone
PCT:
PCT/US2020/022473 ↗
Formulation Including a Combination of Beta-Endorphin and Adrenocorticotropic Hormone
Patent:
11,285,192 →
Application:
17/008,202 →
Publication:
US 2021/0100878
PCT:
PCT/US2020/048813 ↗
Formulation Including a Combination of beta-endorphin and Adrenocorticotropic Hormone
Application:
62/818,034 →
Formulation Including a Combination of beta-Endorphin and Adrenocorticotropic Hormone
Application:
62/981,379 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 12, 2019
From: LOLLO, CHARLES PETER; CARLO, DENNIS J.
To: ADAMIS PHARMACEUTICALS CORPORATION
Reel/Frame 050358/0548 →
Assignment of Assignor's Interest
Feb 28, 2020
From: LOLLO, CHARLES PETER; CARLO, DENNIS J.
To: ADAMIS PHARMACEUTICALS CORPORATION
Reel/Frame 051964/0347 →
Assignment of Assignor's Interest
Mar 13, 2020
From: LOLLO, CHARLES PETER; CARLO, DENNIS J.
To: ADAMIS PHARMACEUTICALS CORPORATION
Reel/Frame 052113/0244 →
Assignment of Assignor's Interest
Aug 31, 2020
From: LOLLO, CHARLES PETER; CARLO, DENNIS J.
To: ADAMIS PHARMACEUTICALS CORPORATION
Reel/Frame 053648/0206 →
Change of Name
Sep 28, 2023
From: ADAMIS PHARMACEUTICALS CORPORATION
To: DMK PHARMACEUTICALS CORPORATION
Reel/Frame 065082/0445 →